Videos

Sandra Cuellar, PharmD, BCOP, discusses challenges with ​data extrapolation for biosimilars. 

Dr. Cuellar on Concerns With Extrapolating Data for Biosimilars 

Lawrence E. Feldman, MD, discusses utilizing prophylactic cranial irradiation in limited-stage and extensive-stage small cell lung cancer. 
 

Dr. Feldman on Prophylactic Cranial Irradiation in SCLC

Articles

Lawrence E. Feldman, MD, discusses exciting new data surrounding immunotherapy combinations in lung cancer.

Immunotherapy Combos Expand Across Lung Cancer Subtypes

Lawrence E. Feldman, MD, medical oncologist, University of Illinois Cancer Center, discusses durvalumab (Imfinzi) for patients with lung cancer.

Dr. Feldman on Durvalumab for Patients With Lung Cancer

Despite the promise of immunotherapy for treating patients with advanced cancers, the success of using such therapies for progressive gastrointestinal malignancies such as colorectal liver metastases (CRLM) has been limited so far.

New Strategy Boosts Microenvironment to Promote Antitumor Immunity in GI Metastases

Given the "addiction" of many tumors to mutant RAS for their survival, there has been renewed interest in developing new ways to inhibit RAS in cancer.

University of Illinois Cancer Center

Latest from University of Illinois Cancer Center

New content coming soon, please check back later.